Table 3.

Results after first-line treatment.

	Cladribine	Pentostatin	“Other” treatments	All treated patients
Follow-up (months), median (range)	116 (21–293)	126 (2–292)	221 (3–413)	128 (2–413)
ORR, n (%)	157 (99)	45 (100)	52 (96)	255 (99)
CR, n (%)	131 (83)	38 (84)	32 (58)	201 (78)
Median RFS (months)	163	159	55	136
CIR
1 year (%)	2.5	4.4	5.5	3.5
5 years (%)	14	13	49	21
10 years (%)	33	30	66	39
Median OS (months)	NR	NR	328	321
OS, evaluable patients
1 year, n (%)	100 (158)	96 (47)	98 (57)	99 (263)
5 years, n (%)	97 (150)	86 (42)	95 (54)	95 (246)
10 years, n (%)	94 (77)	81 (25)	89 (43)	90 (145)
20 years, n (%)	69 (8)	71 (3)	82 (26)	76 (37)